These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9123531)

  • 1. Utility of the pp65 direct antigenemia test in the diagnosis of cytomegalovirus (CMV) in renal transplant recipients.
    Sharma AK; Taylor JD; Tong W; Brown MW; Sells RA; Bakran A
    Transplant Proc; 1997; 29(1-2):799. PubMed ID: 9123531
    [No Abstract]   [Full Text] [Related]  

  • 2. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
    Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
    Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
    Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
    Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation.
    Schröeder R; Michelon T; Fagundes I; Bortolotto A; Petry M; Lammerhirt E; Santos L; Cantarelli V; Keitel E; Garcia V; Neumann J
    Transplant Proc; 2004 May; 36(4):891-3. PubMed ID: 15194306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between pp65 antigenemia, RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients.
    Solà R; Rabella N; Guirado LL; Díaz JM; Facundo C; García R
    Transplant Proc; 2005 Nov; 37(9):3768-9. PubMed ID: 16386533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assay.
    Said T; Nampoory MR; Pacsa AS; Johny KV; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2001 Aug; 33(5):2799-801. PubMed ID: 11498164
    [No Abstract]   [Full Text] [Related]  

  • 8. Early diagnosis of CMV infection by detection of pp65 antigen in 91 renal transplant recipients.
    Lamy ME; Mulongo NK; Vargas M; Pirson Y; Squifflet JP
    Transpl Int; 1994 Jul; 7(4):237-42. PubMed ID: 7916921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies".
    Madhavan HN; Samson MY; Ishwarya M; Vijayakumar R; Jambulingam M
    Virol J; 2010 Nov; 7():322. PubMed ID: 21080922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of flow cytometry for the detection of CMV-specific antigen (pp65) in leukocytes of kidney recipients.
    Essa S; Pacsa AS; Al-Attiyah R; El-Shazly A; Raghupathy R; Said T
    Clin Transplant; 2000 Apr; 14(2):147-51. PubMed ID: 10770420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shell-vial culture and pp65 antigenemia assay in the detection of cytomegalovirus in the first blood sample of renal transplant recipients.
    Reina J; Fernandez-Baca V; Saurina J; Blanco I; Munar M
    J Med Virol; 1998 Jul; 55(3):240-2. PubMed ID: 9624613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
    Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
    Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.
    St George K; Boyd MJ; Lipson SM; Ferguson D; Cartmell GF; Falk LH; Rinaldo CR; Landry ML
    J Clin Microbiol; 2000 Apr; 38(4):1430-3. PubMed ID: 10747120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two commercially available pp65 antigenemia tests and COBAS Amplicor CMV Monitor for early detection and quantification of episodes of human CMV-viremia in transplant recipients.
    May G; Kuhn JE; Eing BR
    Intervirology; 2006; 49(5):261-5. PubMed ID: 16714854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ethylenediaminetetraacetic acid and sodium citrate as anticoagulants in collection of samples for cytomegalovirus pp65 antigen detection in renal transplant recipients with suspected cytomegalovirus disease.
    Patnaik N; Ratho RK; Mishra B; Chakraborty A; Sakhuja VK
    J Virol Methods; 2008 Feb; 147(2):319-21. PubMed ID: 17996957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the CMV brite turbo assay and the digene hybrid capture CMV DNA (Version 2.0) assay for quantitation of cytomegalovirus in renal transplant recipients.
    Ho SK; Li FK; Lai KN; Chan TM
    J Clin Microbiol; 2000 Oct; 38(10):3743-5. PubMed ID: 11015394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.